Federal
Reducing COVID–19 Disparities by Investing in Public Health Act
Source: Congress.gov ·
2,175 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
116TH CONGRESS
2D SESSION
H. R. 6638
To increase the annual funding for the Chronic Disease Prevention and
Health Promotion Fund, the National Institute on Minority Health and
Health Disparities, and the Offices of Minority Health within the Office
of the Secretary of Health and Human Services, the Agency for
Healthcare Research and Quality, the Centers for Disease Control and
Prevention, the Centers for Medicare & Medicaid Services, the Food
and Drug Administration, the Health Resources and Services Administra-
tion, and the Substance Abuse and Mental Health Services Administra-
tion to enable the United States and State departments of public health
to better combat disparities that have emerged during the COVID–
19 crisis and beyond, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
APRIL 28, 2020
Mrs. HAYES introduced the following bill; which was referred to the
Committee on Energy and Commerce
A BILL
To increase the annual funding for the Chronic Disease
Prevention and Health Promotion Fund, the National
Institute on Minority Health and Health Disparities, and
the Offices of Minority Health within the Office of the
Secretary of Health and Human Services, the Agency
for Healthcare Research and Quality, the Centers for
Disease Control and Prevention, the Centers for Medi-
care & Medicaid Services, the Food and Drug Adminis-
tration, the Health Resources and Services Administra-
tion, and the Substance Abuse and Mental Health Serv-
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
2
•HR 6638 IH
ices Administration to enable the United States and
State departments of public health to better combat dis-
parities that have emerged during the COVID–19 crisis
and beyond, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Reducing COVID–19
4
Disparities by Investing in Public Health Act’’.
5
SEC. 2. FINDINGS.
6
The Congress finds the following:
7
(1) Funding under this Act is essential to core
8
efforts at the Department of Health and Human
9
Services and in local and State health departments
10
to prevent and control the spread of chronic disease
11
and conditions. The National Center for Chronic
12
Disease Prevention and Health Promotion works to
13
raise awareness of health disparities faced by minor-
14
ity populations of the United States such as Amer-
15
ican Indians, Alaska Natives, Asian Americans, Afri-
16
can Americans, Latino Americans, and Native Ha-
17
waiians or other Pacific Islanders. One of the pri-
18
mary functions of the Center is to reduce risk fac-
19
tors for groups affected by health disparities.
20
(2) Six in ten Americans live with at least one
21
chronic disease, like heart disease and stroke, can-
22
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
3
•HR 6638 IH
cer, or diabetes. These and other chronic diseases
1
are the leading causes of death and disability in
2
America. Specifically, chronic diseases are respon-
3
sible for 7 in 10 deaths each year. According to the
4
Centers
for
Disease
Control
and
Prevention
5
(‘‘CDC’’), individuals who are at high risk for severe
6
illness from COVID–19 are people with chronic lung
7
disease or moderate to severe asthma, people with
8
serious heart conditions, people who are immuno-
9
compromised—sometimes because of cancer or HIV/
10
AIDS, people with diabetes, people with liver dis-
11
ease, people with severe obesity, and people with
12
chronic kidney disease undergoing dialysis.
13
(3) According to hospital data from the first
14
month of the COVID–19 epidemic in the United
15
States released by the CDC, roughly 1 in 3 people
16
who required hospitalizations from COVID–19 were
17
African American. While 33 percent of total hos-
18
pitalized patients are Black, African Americans con-
19
stitute just 13 percent of the entire American popu-
20
lation. Early data released by States and municipali-
21
ties show that African Americans suffer higher mor-
22
tality rates from COVID–19. Socioeconomic factors
23
further contribute to racial disparities seen in both
24
prevalence of chronic conditions and exposure to
25
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
4
•HR 6638 IH
COVID–19. Individuals in low-income communities
1
and people of color are more likely to have many of
2
the chronic health conditions that have been identi-
3
fied as risk factors for complications from COVID–
4
19, yet suffer decreased access to care, compounded
5
by a decreased likelihood of undergoing appropriate
6
treatment.
7
(4) According to the American Diabetes Asso-
8
ciation, 12.1 percent of Hispanic Americans, 12.7
9
percent of African Americans, 8 percent of Asian
10
Americans, and 15.1 percent of American Indians/
11
Alaska Natives have been diagnosed with diabetes,
12
compared to just 7.4 percent of White Americans.
13
The CDC calculated that compared to non-Hispanic
14
Whites, Hispanics are 40 percent more likely to die
15
from diabetes, African Americans are twice as likely
16
to die from diabetes, and American Indians/Alaska
17
Natives are almost twice as likely to die from the
18
disease.
19
(5) According to the National Institutes of
20
Health, African Americans are more than 30 percent
21
more likely to die from heart disease, are twice as
22
likely to have a stroke—which tends to be more se-
23
vere with a higher morbidity and results in higher
24
mortality, are 40 percent more likely to have high
25
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
5
•HR 6638 IH
blood pressure, and have a higher rate of hyper-
1
tension and heart failure than their White counter-
2
parts.
3
(6) Minority groups suffer from asthma at a
4
disproportionate rate, have the highest number of
5
emergency room visits and hospital stays due to
6
asthma, and have higher mortality rates from asth-
7
ma than their White counterparts. The prevalence of
8
childhood asthma for African Americans is 12.7 per-
9
cent compared to 8 percent for White Americans,
10
while mortality rates in children and adults are
11
eightfold and threefold higher, respectively, for Afri-
12
can Americans compared to White Americans.
13
(7) President Trump has consistently proposed
14
budgets that would cut the Chronic Disease Preven-
15
tion and Health Promotion Fund. In fiscal year
16
2021, the President proposed to consolidate the
17
CDC’s primary chronic disease prevention activities,
18
including tobacco, diabetes, heart disease, and
19
stroke, and nutrition and physical activity, into a
20
single block grant to States, while proposing a
21
$427,000,000 cut to the account. In fiscal year
22
2020, the President proposed a $236,500,000 cut to
23
the account. In fiscal year 2019, the President pro-
24
posed a $138,300,000 cut to the account. In fiscal
25
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
6
•HR 6638 IH
year 2018, the President proposed a $222,300,000
1
cut to the account.
2
(8) Cuts to this Fund and other public health
3
prevention efforts undermine efforts to create an af-
4
fordable and accessible health care system, and a
5
better quality of life for Americans of all ethnic, ra-
6
cial, and socioeconomic backgrounds. Cuts to this
7
Fund would also exacerbate existing disparities and
8
underlying health conditions that have created seem-
9
ingly vast disparities in hospitalization and mortality
10
rates due to COVID–19.
11
(9) Prevention efforts have proven to be effec-
12
tive. Funding increases for community-based public
13
health programs reduce preventable disease caused
14
by diabetes, cancer, and cardiovascular disease. Im-
15
proved access to intervention, treatment, and afford-
16
able care is also proven to mitigate the development
17
of associated chronic diseases and mortality rates.
18
(10) Increasing the Chronic Disease Prevention
19
and
Health
Promotion
Fund
funding
to
20
$2,400,000,000 annually will allow the Fund to in-
21
vest in more innovative, evidence-based public health
22
programs, maintain and expand investments in pro-
23
grams with demonstrated success, and help reduce
24
racial health disparities and rates of chronic disease
25
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
7
•HR 6638 IH
that can put persons of color at greater risk of hos-
1
pitalization or death from COVID–19.
2
(11) Further, the Office of Minority Health in
3
the Office of the Secretary of Health and Human
4
Services (established by section 1707 of the Public
5
Health Service Act (42 U.S.C. 300u–6)) was de-
6
signed for the purpose of ‘‘improving minority health
7
and the quality of health care minorities receive, and
8
eliminating racial and ethnic disparities’’. The Office
9
of Minority Health and Health Equity at the CDC
10
serves to decrease health disparities, address social
11
determinants of health, and promote access to high-
12
quality preventative health care. The Office of Mi-
13
nority Health and Health Equity at the Food and
14
Drug Administration promotes and protects the
15
health of diverse populations through research and
16
communication of science that addresses health dis-
17
parities. The National Institute on Minority Health
18
and Health Disparities leads scientific research that
19
advances understanding of minority health and
20
health disparities.
21
(12) Increasing funding for these and other
22
critical health programs will enable the United
23
States and State departments of public health to
24
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
8
•HR 6638 IH
better combat disparities that have emerged during
1
the COVID–19 crisis and beyond.
2
SEC. 3. REDUCING COVID–19 DISPARITIES BY INVESTING IN
3
PUBLIC HEALTH.
4
(a) CHRONIC DISEASE PREVENTION AND HEALTH
5
PROMOTION.—There is authorized to be appropriated, and
6
there is hereby appropriated, out of any money in the
7
Treasury not otherwise appropriated, for ‘‘Centers for
8
Disease Control and Prevention—Chronic Disease Preven-
9
tion and Health Promotion’’, for fiscal year 2020 and each
10
subsequent fiscal year, $2,400,000,000.
11
(b) NATIONAL INSTITUTE ON MINORITY HEALTH
12
AND HEALTH DISPARITIES.—There is authorized to be
13
appropriated, and there is hereby appropriated, out of any
14
money in the Treasury not otherwise appropriated, to the
15
National Institute on Minority Health and Health Dis-
16
parities, for fiscal year 2020 and each subsequent fiscal
17
year, $672,000,000.
18
(c) OFFICE OF MINORITY HEALTH.—There is au-
19
thorized to be appropriated, and there is hereby appro-
20
priated, out of any money in the Treasury not otherwise
21
appropriated, to the Office of Minority Health in the Of-
22
fice of the Secretary of Health and Human Services (es-
23
tablished by section 1707 of the Public Health Service Act
24
(42 U.S.C. 300u–6)), for fiscal year 2021 and each subse-
25
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
9
•HR 6638 IH
quent fiscal year, the amount that is twice the amount
1
of funds made available to such Office of Minority Health
2
for fiscal year 2020.
3
(d) OTHER OFFICES OF MINORITY HEALTH WITHIN
4
THE DEPARTMENT
OF HEALTH
AND HUMAN SERV-
5
ICES.—There is authorized to be appropriated, and there
6
is hereby appropriated, out of any money in the Treasury
7
not otherwise appropriated, to the Office of Minority
8
Health of the Agency for Healthcare Research and Qual-
9
ity, the Office of Minority Health of the Centers for Dis-
10
ease Control and Prevention, the Office of Minority
11
Health of the Centers for Medicare & Medicaid Services,
12
the Office of Minority Health of the Food and Drug Ad-
13
ministration, the Office of Minority Health of the Health
14
Resources and Services Administration, and the Office of
15
Minority Health of Substance Abuse and Mental Health
16
Services Administration (as established pursuant to sec-
17
tion 1707A of the Public Health Service Act (42 U.S.C.
18
300u–6a)), for fiscal year 2021 and each subsequent fiscal
19
year, the amount that is twice the amount of funds made
20
available to the respective Office of Minority Health for
21
fiscal year 2020.
22
Æ
VerDate Sep 11 2014
03:36 May 01, 2020
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6301
E:\BILLS\H6638.IH
H6638
kjohnson on DSK79L0C42PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.